These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3893513)

  • 41. [Flubenisolonvalerate and fluocinolonacetonide in the treatment of skin diseases. A double-blind study].
    Thomsen K
    Ugeskr Laeger; 1966 Nov; 128(47):1391-3. PubMed ID: 5342507
    [No Abstract]   [Full Text] [Related]  

  • 42. Fluocinolone acetonide 0.2 per cent cream--a co-operative clinical trial.
    Marsden CW
    Br J Dermatol; 1968 Sep; 80(9):614-7. PubMed ID: 4877599
    [No Abstract]   [Full Text] [Related]  

  • 43. [On the dermatological use of a fluocinolone acetonide ointment, with special reference to topical therapy of psoriasis].
    Zar E
    Minerva Med; 1971 Apr; 62(27):1418-27. PubMed ID: 5553842
    [No Abstract]   [Full Text] [Related]  

  • 44. Comparative study of desoximetasone ointment 0.25% versus fluocinonide ointment 0.05% in patients with psoriasis.
    Clin Ther; 1985; 8(1):118-25. PubMed ID: 3914368
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of amcinonide ointment 0.1 percent twice daily and fluocinonide ointment 0.05 percent three times daily in the treatment of psoriasis.
    Cornell RC
    Cutis; 1983 May; 31(5):566-9. PubMed ID: 6851655
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of two therapeutic regimens using the same topical corticoid for stable psoriasis.
    Senter TP; Stimson DH; Charles G; Brand RJ
    West J Med; 1983 Nov; 139(5):657-62. PubMed ID: 6362203
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Synalar in the treatment of psoriasis and several other chronic dermatoses].
    Ashmarin IuIa; Amitan BIa
    Vestn Dermatol Venerol; 1966 Apr; 40(4):81-3. PubMed ID: 5988466
    [No Abstract]   [Full Text] [Related]  

  • 48. [On the effectiveness of highly concentrated fluocinolone acetonide cream in various skin diseases].
    Gebhardt R; Holzmann H
    Med Welt; 1969 Mar; 9():484-8. PubMed ID: 5771355
    [No Abstract]   [Full Text] [Related]  

  • 49. [Treatment of otitis media with Synalar and Synalar N preparations].
    Moszyński B; Piotrowska A
    Otolaryngol Pol; 1977; 31(5):511-5. PubMed ID: 600525
    [No Abstract]   [Full Text] [Related]  

  • 50. Efficacy and safety of fluocinolone acetonide 0.025% otic solution in patients with otic eczema: a randomized, double-blind, placebo-controlled clinical trial.
    Montoro V; Asensio C; Martínez Á; Lorente J; Rodríguez FJ; Montojo J; Gavilanes J; Sarría P; Langdon C; Prades E
    J Int Med Res; 2018 Oct; 46(10):4050-4060. PubMed ID: 30141364
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Fluocinolone acetonide in treatment of patients with some chronic dermatoses].
    Araviĭskiĭ AN; Chaĭka NA
    Sov Med; 1968 Dec; 31(12):65-70. PubMed ID: 5736555
    [No Abstract]   [Full Text] [Related]  

  • 52. A multicentre trial of "metosyn"--a new topical steroid in a complex two phase base.
    Nicholls JT
    Curr Ther Res Clin Exp; 1972 May; 14(5):259-63. PubMed ID: 4623977
    [No Abstract]   [Full Text] [Related]  

  • 53. [The antipsoriatic effect of cignolin in comparison (autoradiographic and histochemical) with fluocinolone acetonide].
    Kalkoff KW; Born W; Reinhard W
    Arch Klin Exp Dermatol; 1966; 227(1):857-66. PubMed ID: 5984847
    [No Abstract]   [Full Text] [Related]  

  • 54. [Interval treatment with local corticosteroids and bases].
    Schmid P
    Fortschr Med; 1981 Jul; 99(27-28):1102-4. PubMed ID: 7262795
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Local treatment of eczema with flupamesone. Double blind study with fluocinolone acetonide].
    Rodríguez Moreno T; Rodríguez Cañas T
    Rev Clin Esp; 1976 Aug; 142(3):255-60. PubMed ID: 788066
    [No Abstract]   [Full Text] [Related]  

  • 56. Design, characterization and skin permeating potential of Fluocinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis.
    Pradhan M; Singh D; Murthy SN; Singh MR
    Steroids; 2015 Sep; 101():56-63. PubMed ID: 26049018
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Diflucortolone valerianate and fluocinolone acetonide in eczema and dermatitis. Interindividual randomized double-blind study with 124 patients].
    van Zuiden E
    Ther Ggw; 1978 Aug; 117(8):1248-64. PubMed ID: 356333
    [No Abstract]   [Full Text] [Related]  

  • 58. A comparison of the effect of various topically active steroids on the clinical and histological features of psoriasis.
    Goodwin PG; Hamilton S; Fry L
    Br J Dermatol; 1973 Jul; 89(1):61-6. PubMed ID: 4596154
    [No Abstract]   [Full Text] [Related]  

  • 59. [Double-blind comparative study between difluocortolone-valerianate and fluocinolone-acetonide ointments].
    Capellini Gaya E
    Prensa Med Mex; 1977; 42(3-4):183-6. PubMed ID: 335382
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and Safety of Ciprofloxacin Plus Fluocinolone in Otitis Media With Tympanostomy Tubes in Pediatric Patients: A Randomized Clinical Trial.
    Spektor Z; Pumarola F; Ismail K; Lanier B; Hussain I; Ansley J; Butehorn HF; Esterhuizen K; Byers J; Douglis F; Lansford B; Hernández FJ
    JAMA Otolaryngol Head Neck Surg; 2017 Apr; 143(4):341-349. PubMed ID: 28006041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.